制药产业创新激励政策研究的述评与展望

摘要

Based on the typical characteristics of existing incentive and regulation in the pharmaceutical industry in China,the innovation incentive policy of the pharmaceutical industry can be divided into two types:incentive policy,and regulatory policy.This paper reviewed the research progress on the influence of price regulation policy,health insurance payment policy,centralized procurement regulation and incentive policy on the innovation of pharmaceutical industry.The present paper puts also forward the future research direction.Based on the literature review,it has been found that the futnre researches in this field should be based on the management practice situation in China,and make a breakthrough from the following three aspects-asymmetric information,comprehensive action mechanism from variable policy instruments,and introduction of new research paradigm.This research provides a theoretical reference for the research and decision-making of the innovation incentive policy in the pharmaceutical industry.%基于制药产业激励与规制并存的典型特征,将制药产业创新激励政策划分为激励性政策和规制性政策两大类.通过国内外相关文献的梳理,就价格管制政策、医保支付政策、集中采购规制以及创新药研发激励政策对制药产业创新激励影响的研究进展进行了梳理和述评,提出未来该领域的研究应立足于中国的管理实践,从非对称信息、多种政策工具对创新药研发激励的综合作用机制,以及引入新的研究范式等三个方面进行突破.